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Ouabain and Serum Sodium
To the Editor:
Sodium-dependent mechanisms play a role in the pathogenesis
of hypertension. He et al recently demonstrated that in normo-
tensive and hypertensive subjects an acute reduction in salt
intake, from 350 to 10 mmol/d for 5 days, was associated with a
decline in serum sodium by 3 mmol/L.1 Conversely, a progres-
sive increase in salt intake from 10 to 250 mmol/d by a daily
amount of 50 mmol caused an increase in serum sodium in
normotensive subjects, but not hypertensive patients.1 These
investigators speculated that small changes in serum sodium
might directly affect the hypothalamic control of blood pressure
through the local pituitary renin-angiotensin system.1
Ouabain is a steroid hormone, which is released from the
hypothalamus and the adrenal gland. It is implicated in sodium
homeostasis and exerts direct actions on the vasculature, the
heart,2 and tubular sodium reabsorption.3 In individuals ran-
domly recruited from a Flemish population, blood pressure
increased by 2.2 mm Hg systolic and 1.4 mm Hg diastolic for
each 50-mmol/d increment in urinary sodium excretion when the
plasma ouabain concentration was below the median (140
pmol/L).4 No association between blood pressure and urinary
sodium was found when plasma ouabain exceeded the median.4
In the same population,4 we tried to reproduce He’s observa-
tions in 369 subjects not using treatment with diuretics. Blood
pressure was the average of 5 consecutive readings obtained at
each of 2 home visits 4 to 6 weeks apart. The study sample
included 48.0% men, 30.9% current smokers, and 25.5% hyper-
tensive patients. Mean age was 39.816.7 (SD) years. Mean
values for systolic/diastolic blood pressure, serum sodium, and
the 24-hour urinary sodium excretion were 12315/
7711 mm Hg, 141.62.5 mmol/L, and 19261 (range, 24 to
391) mmol/d, respectively. The geometric mean concentration of
plasma ouabain was 145 (95% confidence interval, 138 to 148)
pmol/L. With adjustment for sex, age, body mass index, and
current smoking, serum sodium did not increase with sodium
excretion (partial r0.01, P0.88). However, with similar
adjustments, we found an independent and positive relation
between the serum concentrations of sodium and ouabain with a
partial correlation coefficient of 0.12 (95% confidence interval,
0.02 to 0.22, P0.03). In a sensitivity analysis only including
334 untreated subjects, the partial correlation coefficient was
0.11 (95% confidence interval, 0.00 to 0.22, P0.06). This
relation was stronger in men than in women (r0.18 versus
r0.03, respectively; P0.001).
In conclusion, our observational study in Flemish subjects free
from antihypertensive therapy did not confirm that serum sodium
increased with urinary sodium excretion. However, in line with
the perspectives of He’s recent article,1 we noticed that the serum
sodium concentration, which is a tightly regulated variable, is
positively and independently correlated with plasma ouabain, a
hypothalamic and adrenal hormone. Further research should
assess whether this association is direct, whether it is mediated
via extracellular volume or endocrine factors, and whether it is
different in women and men.
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Response: Ouabain and Serum Sodium
We are grateful to Gasowski et al for raising an interesting
point on plasma sodium and ouabain. They found a significant
association between these 2 variables in a cross-sectional study
of 369 individuals.1 This finding, in conjunction with those from
experimental studies in rats,2 which showed that the increase in
blood pressure induced by an increase in cerebral spinal fluid
sodium was secondary to an increase in ouabain content in the
hypothalamus, and could be prevented by the intracerebroven-
tricular administration of Fab fragments, which bound ouabain,
suggests that the effect of plasma sodium on blood pressure may
be, in part, through increasing ouabain concentration both in
plasma and in the hypothalamus.
In our article,3 we looked at 3 types of studies of changing salt
intake and demonstrated that when salt intake is increased or
decreased, there is a parallel change in plasma sodium. Small
changes in plasma sodium alter extracellular volume, which may
influence blood pressure. At the same time, changes in plasma
sodium may also affect blood pressure directly. It is an important
attempt that Gasowski et al tried to reproduce these findings
using the data of their cross-sectional study, presumably trying to
answer an important question of whether habitual salt intake is
related to plasma sodium. However, addressing this question
would need careful measurements of both plasma and urinary
sodium in a large number of individuals under controlled
conditions because of a large day-to-day variation in salt intake.
In addition, the concentration of sodium in plasma is closely and
rapidly controlled by the movement of fluid between the intra-
cellular and extracellular compartment, changes in sodium ex-
cretion, and by the activity of thirst center,4 which, in rat, is
influenced by changes in plasma sodium of 1%.5 Such small
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and potent changes in plasma sodium are technically difficult
to detect. The methods used in the cross-sectional study by
Gasowski et al made it even more difficult to look at the
relationship between salt intake and plasma sodium. First, only
one 24-hour urine collection was made, which certainly does not
represent an individual’s habitual salt intake. Furthermore, blood
sample was taken several days after the urine collection (“usually
within 2 weeks of urine collection” as stated in the original
publication1). It is therefore not surprising that they could not
reproduce our findings from well-controlled clinical trials.
Gasowski et al also misquoted our results by stating that “a
progressive increase in salt intake from 10 to 250 mmol/d by a
daily amount of 50 mmol caused an increase in plasma sodium in
normotensive subjects, but not hypertensive patients.” In our
article, we clearly indicated that only normotensive individuals
were studied using this protocol (ie, progressive increase in salt
intake). However, our acute salt reduction studies in which both
hypertensive subjects and normotensive subjects were studied,
showed a similar decrease in plasma sodium when salt intake
was reduced from 350 to 10 mmol/d. Therefore, there is no
reason to believe that hypertensive individuals would not show
an increase in plasma sodium with increasing salt intake.
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